Znaczenie aktywności proteazy kapsydowej CP w rozwoju infekcji alfawirusowych

• Autorzy: Torzyk Karolina , Skoreński Marcin , Sieńczyk Marcin

Identyfikatory

DOI

10.53584/wiadchem.2022.5.3

Warianty tytułu

EN

The role of capsid protease CP activity in the development of alphaviral infections

• Języki publikacji: PL

Abstrakty

EN

Alphaviruses belong to the worldwide distributed Togaviridae family and Alphavirus genus. They are spherical, enveloped, single-stranded RNA arthropodborne viruses. Alphaviruses are mostly transmitted by mosquitoes (Aedes spp. and Anopheles spp.) and are geographically distributed in restricted areas where appropriate vectors are present (Fig.1.). The most recognized members of this genus are Sindbis (SINV), Semliki Forest (SFV), Venezuelan equine encephalitis (VEEV), Ross River (RRV), and Chikungunya (CHIKV) viruses. Alphaviruses are infection agents for humans and many animals. Clinically, most human infections with arthritogenic alphaviruses are associated with symptoms such as fever, headache, joint pain, rash, chronic arthritis, and encephalitis. Major events during the alphaviral infection are virus entry, replication, assembly, and budding of new virions. Alphaviral RNA encodes four nonstructural and five structural proteins. Nonstructural proteins are mainly involved in the replication process and virus pathogenesis, while structural proteins form new virions. Both groups of viral proteins are produced as single polyproteins which undergo autoproteolytic maturation. This process is carried out by the two viral proteases, cysteine protease nsP4 and C protein serine protease (CP), and is considered to be critical for virus replication. The capsid protease CP is a chymotrypsin-like serine protease with the catalytic triad including His₁₄₅, Asp₁₆₇, and Ser₂₁₉. What is important, after a suicidal autoproteolytic event the side chain of Trp₂₆₇ remains bound in a hydrophobic S1 pocket thus inhibiting further trans-proteolytic activity. Alphaviral capsid protein undergoes a single proteolytic reaction before maturation and then, after selfinactivation, it assembles to form a viral capsid shell. Inhibitors of the capsid protease have significant antiviral activity. Compounds belonging to this group can be good candidates for new antiviral drugs.

Słowa kluczowe

PL

alfawirusy; arbowirusy; proteazy serynowe; proteaza kapsydowa CP; inhibitory

EN

alphaviruses; arboviruses; serine proteases; capsid protease CP; inhibitors

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Wiadomości Chemiczne
• Rocznik: 2022
• Tom: [Z] 76, 5-6
• Strony: 309--321
• Opis fizyczny: Bibliogr. 46 poz., rys., wykr.

Twórcy

autor

Torzyk Karolina

• Katedra Chemii Organicznej i Medycznej, Wydział Chemiczny, Politechnika Wrocławska, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Polska

• https://orcid.org/0000-0003-3432-2529

autor

Skoreński Marcin

• Katedra Chemii Organicznej i Medycznej, Wydział Chemiczny, Politechnika Wrocławska, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Polska

• https://orcid.org/0000-0001-8578-8957

autor

Sieńczyk Marcin

• Katedra Chemii Organicznej i Medycznej, Wydział Chemiczny, Politechnika Wrocławska, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Polska

• https://orcid.org/0000-0002-5528-5264

Bibliografia

• 1] B. Fatma, R. Kumar, V.A. Singh, S. Nehul, R. Sharma, P. Kesari, R.J. Kuhn, S. Tomar, Antiviral Res., 2020, 179, 104808.
• [2] J.R. Hwu, M. Kapoor, N.K. Gupta, S.C. Tsay, W.C. Huang, K.T. Tan, Y-C. Hu, P. Lyssen, J. Neyts, Eur. J. Med. Chem., 2022, 232, 114164.
• [3] J. Verma, N. Subbarao, J. Biomol. Struct. Dyn., 2022, 40, 2048080.
• [4] P. Sharma, P. Sharma, S. Ahmad, A. Kumar, Int. J. Pept. Res. Ther., 2022, 28, 50.
• [5] J. Waggoner, C.J. Heath, B. Ndenga, F. Mutuku, M.K. Sahoo, A. Mohamed-Hadley, J. Vulule, D. Mukoko, A. Desiree LaBeaud, B.A. Pinsky, Am. J. Trop. Med. Hyg., 2017, 97, 121.
• [6] A. Septembre-Malaterre, Y. Bedoui, C. Giry, P. Gasque, P. Guiraud, J. Sélambarom, Sci. Rep., 2021, 11, 6369.
• [7] L. Pezzi, M. Diallo, M.G. Rosa-Freitas, A. Vega-Rua, L.F.P. Ng, S. Boyer, J.F. Drexler, N. Vasilakis, R. Lourenco-de-Oliveira, S.C. Weaver, A. Kohl, X. de Lamballerie, A-B. Failloux, Antiviral Res., 2020, 174, 104670.
• [8] G.J. Atkins, International Scholarly Research Notices, 2012, 2013, 861912.
• [9] M. Laine, R. Luukkainen, A. Toivanen, J. Intern. Med., 2004, 256, 457.
• [10] H. Artsob, R. Lindsay, M. Drebot, International Encyclopedia of Public Health, Elsevier Inc., 2017, 154.
• [11] J.D. Beckham, K.L. Tyler, Neuroinfectious Disease, 2015, 21, 1599.
• [12] A. Suhrbier, M-C. Jaffar-Bandjee, P. Gasque, Nature Reviews Rheumatology, 2012, 8, 420.
• [13] R.S.S. Azevedo, E.V.P. Silva, V.L. Carvalho, S.G. Rodrigues, J.P.N. Neto, H.A.O. Monteiro, V.S. Peixoto, J.O. Chiang, M.R.T. Nunes, P.F.C. Vasconcelos, Emerg. Infect. Dis., 2009, 15, 1830.
• [14] D. Harley, A. Sleigh, S. Ritchie, Clin. Microbiol. Rev., 2001, 14, 909.
• [15] A.S. Lima Neto, G.S. Sousa, O.J. Nascimento, M.C. Castroid, PLoS. Negl. Trop. Dis., 2019, 13, e0007575.
• [16] Å. Gylfe, Å. Ribers, O. Forsman, G. Bucht, G-M. Alenius, S. Wållberg-Jonsson, C. Ahlm, M. Evander, Emerg. Infect. Dis., 2018, 24, 1141.
• [17] S. Adouchief, T. Smura, J. Sane, O. Vapalahti, S. Kurkela, Rev. Med. Virol., 2016, 26, 221.
• [18] M. Skogh, Å. Espmark, The Lancet, 1982, 1, 795.
• [19] C. Lorenz, A. Freitas Ribeiro, F. Chiaravalloti-Neto, Acta. Trop., 2019, 198, 105093.
• [20] R.C. Russell, Annu. Rev. Entomol., 2002, 47, 1.
• [21] W. Qian, C. Hurs, K. Glass, D. Harley, E. Viennet, Trop. Med. Infect. Dis., 2021, 6, 145.
• [22] A.M. Powers, C.H. Logue. J. Gen. Virol., 2007, 88, 2363.
• [23] S. Hossain, M.R. Choudhury, Md.A. Islam, Md.M. Hassan, S. Yeasmin, F. Hossain, M.M. Zaman, Trop. Med. Health., 2022, 50, 21.
• [24] E.J. Sanders, E.B. Rwaguma, J. Kawamata, N. Kiwanuka, J.J. Lutwama, F.P. Ssengooba, R. Najjemba, W.A. Were, M. Lamunu, G. Bagambisa, T.R. Burkot, L. Dunster, J.J. Lutwama, D.A. Martin, C.B. Cropp, N. Karabatsos, R.S. Lanciotti, T.F. Tsai, G.L. Campbellet, Clin. Infect. Dis., 1999, 29, 1243.
• [25] G. Rezza, R. Chen, S.C. Weaver, Pathog. Glob. Health, 2017, 111, 271.
• [26] R.J. Schoepp, T.L. Clements, C.A. Rossi, A.K. Irish, K. Kibuuka, L.A. Eller, L.M. Robb, P. Kataaha, N.L. Michael, L.E. Hensley, R.J. Schoepp, Open Forum Infect. Dis., 2019, 6, ofz001.
• [27] M.C. Williams, J.P. Woodall, J.D. Gillett, Trans. R. Soc. Trop. Med. Hyg., 1965, 59, 186.
• [28] W.G. Lima, R.S. Pereira, W.S. da Cruz Nizer, J.C.M. Brito, I.P. Godoi, V.N. Cardoso, S.O.A. Fernandes, J.M.S. Ferreira, Arch. Virol., 2021, 166, 347.
• [29] M. Brummer-Korvenkontio, O. Vapalahti, P. Kuusisto, P. Saikku, T. Manni, P. Koskela, T. Nygren, H. Brummer-Korvenkontio, A. Vaheri, Epidemiol Infect., 2002, 129, 335.
• [30] F. Simon, H. Savini, P. Parola, Med. Clin. North. Am., 2008, 92, 1323.
• [31] J.E. Erin, R.F. Breiman, A.M. Powers, Clin. Infect. Dis., 2009, 49, 942.
• [32] S. Mukhopadhyay, W. Zhang, S. Gabler, P.R. Chipman, E.G. Strauss, J.H. Strauss, T.S. Baker, R.J. Kuhn, M.G. Rossmann, Structure, 2006, 14, 63.
• [33] R.S. Levinson, J.H. Strauss, E.G. Strauss, Virology, 1990, 175, 110.
• [34] E.G. Strauss, C.M. Rice, J.H. Strauss, Virology, 1984, 133, 92.
• [35] G. Shin, S.A. Yost, M.T. Miller, E.J. Elrod, A. Grakoui, J. Marcotrigiano, Proc. Natl. Acad. Sci. USA, 2012, 109, 16534.
• [36] J. Yat-Sing Leung, M. Mah-Lee Ng, J. Jang Hann Chu, Adv. Virol., 2011, 2011, 249640.
• [37] J. Jose, J.E. Snyder, R. Kuhn, Future Microbiol., 2009, 4, 837.
• [38] E.M. Hong, R. Perera, R.J. Kuhn, Viruses, 2018, 10, 138.
• [39] R. Perera, K.E. Owen, T.L. Tellinghuisen, A.E. Gorbalenya, R.J. Kuhn, J. Virol., 2001, 75, 1.
• [40] H-K. Choi, L. Tong, W. Minor, P. Dumas, U. Boege, M.G. Rossmann, G. Wengler, Nature, 1991, 354, 37.
• [41] L. Tong, G. Wengler, M.G. Rossmann, J. Mol. Biol., 1993, 230, 228.
• [42] S. Thomas, J. Rai, L. John, S. Günther, C. Drosten, B.M. Pützer, S. Schaefer, Virol. J., 2010, 7, 327.
• [43] M. Morillas, H. Eberl, F.H.T. Allain, R. Glockshuber, E. Kuennemann, J. Mol. Biol., 2008, 376, 721.
• [44] M. Aggarwal, R. Sharma, P. Kumar, P. Manmohan, S. Tomar, Sci. Rep., 2015, 5, 14753.
• [45] M. Aggarwal, S. Dhindwal, P. Kumar, R.J. Kuhn, S. Tomar, J. Virol., 2014, 88, 12242.
• [46] M. Aggarwal, R. Kaura, A. Saha, R. Mudgal, R. Yadav, P. K. Dash, M. Parida, P. Kumar, S. Tomar, Antiviral Res., 2017, 146, 102.